Samra Turajlic

20.5k total citations · 6 hit papers
98 papers, 4.9k citations indexed

About

Samra Turajlic is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Samra Turajlic has authored 98 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Oncology, 40 papers in Molecular Biology and 33 papers in Cancer Research. Recurrent topics in Samra Turajlic's work include Cancer Immunotherapy and Biomarkers (39 papers), Cancer Genomics and Diagnostics (30 papers) and Renal cell carcinoma treatment (17 papers). Samra Turajlic is often cited by papers focused on Cancer Immunotherapy and Biomarkers (39 papers), Cancer Genomics and Diagnostics (30 papers) and Renal cell carcinoma treatment (17 papers). Samra Turajlic collaborates with scholars based in United Kingdom, United States and Australia. Samra Turajlic's co-authors include Charles Swanton, James Larkin, Martin Gore, Andrea Sottoriva, Trevor A. Graham, Richard Marais, Lavinia Spain, Simon J. Furney, Malin Pedersen and Kevin Litchfield and has published in prestigious journals such as Science, Cell and Nature Medicine.

In The Last Decade

Samra Turajlic

92 papers receiving 4.9k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis

2017 662 citations Samra Turajlic, Kevin Litchfield et al. profile →
Metastasis as an evolutionary process

2016 462 citations Samra Turajlic, Charles Swanton profile →
Resolving genetic heterogeneity in cancer

2019 407 citations Samra Turajlic, Charles Swanton et al. profile →
The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours

2022 399 citations Holger Moch, Mahul B. Amin et al. European Urology profile →
The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs—Part B: Prostate and Urinary Tract Tumors

2022 140 citations George J. Netto, Mahul B. Amin et al. European Urology profile →
COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety

2022 110 citations Annika Fendler, Elisabeth G.E. de Vries et al. Nature Reviews Clinical Oncology profile →

Peers

Countries citing papers authored by Samra Turajlic

Since Specialization

Citations

This map shows the geographic impact of Samra Turajlic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samra Turajlic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samra Turajlic more than expected).

Fields of papers citing papers by Samra Turajlic

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samra Turajlic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samra Turajlic. The network helps show where Samra Turajlic may publish in the future.

Co-authorship network of co-authors of Samra Turajlic

This figure shows the co-authorship network connecting the top 25 collaborators of Samra Turajlic. A scholar is included among the top collaborators of Samra Turajlic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samra Turajlic. Samra Turajlic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Therapeutic inhibition of monocyte recruitment prevents checkpoint inhibitor-induced hepatitis 2024 ·Journal for ImmunoTherapy of Cancer ·Cathrin Gudd, (unknown), Stephen R. Atkinson, (unknown), Samra Turajlic, James Larkin, Mark Thursz, Robert Goldin, Nick Powell, Charalambos G. Antoniades, Kevin Woollard, Lucia Possamai, Evangelos Triantafyllou	3
2	Saturation genome editing maps the functional spectrum of pathogenic VHL alleles 2024 ·Nature Genetics ·(unknown), (unknown), Athina Ganner, Laura Cubitt, (unknown), Dong‐Kyu Kim, (unknown), (unknown), (unknown), Joachim De Jonghe, Scott T.C. Shepherd, Chelsea Sawyer, (unknown), Sven Diederichs, Elke Neumann‐Haefelin, Samra Turajlic, Evgueni A. Ivakine, Gregory M. Findlay	16
3	Interpretability of radiomics models is improved when using feature group selection strategies for predicting molecular and clinical targets in clear-cell renal cell carcinoma: insights from the TRACERx Renal study 2023 ·Cancer Imaging ·Matthew Orton, (unknown), Simon Doran, Scott T.C. Shepherd, Derfel ap Dafydd, Charlotte Spencer, José I. López, (unknown), Francesca Comito, Hannah Warren, Joshua Shur, Christina Messiou, James Larkin, Samra Turajlic, Dow‐Mu Koh	8
4	COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety breakdown → 2022 ·Nature Reviews Clinical Oncology ·Annika Fendler, Elisabeth G.E. de Vries, Corine H. GeurtsvanKessel, John B.A.G. Haanen, Bernhard Wörmann, Samra Turajlic, Marie von Lilienfeld‐Toal	110
5	WHO 2022 classification of penile and scrotal cancers: updates and evolution 2022 ·Histopathology ·Santosh Menon, Holger Moch, Daniel M. Berney, (unknown), (unknown), Toyonori Tsuzuki, Éva Compérat, Arndt Hartmann, George J. Netto, Mark A. Rubin, (unknown), Samra Turajlic, PH Tan, (unknown), (unknown), Mahul B. Amin	21
6	What's new in WHO fifth edition – urinary tract 2022 ·Histopathology ·Éva Compérat, Mahul B. Amin, Daniel M. Berney, Ian A. Cree, Santosh Menon, Holger Moch, George J. Netto, (unknown), (unknown), Mark A. Rubin, John R. Srigley, Puay Hoon Tan, Satish K. Tickoo, Samra Turajlic, Toyonori Tsuzuki	16
7	Oral beclomethasone dipropionate is an effective treatment for immune checkpoint inhibitor induced colitis 2022 ·Journal for ImmunoTherapy of Cancer ·James L. Alexander, Hajir Ibraheim, (unknown), Benjamin Shum, Polychronis Pavlidis, Nikki Hunter, Julian Teare, Andrew Wotherspoon, Andrew J.S. Furness, Samra Turajlic, Lisa Pickering, James Larkin, Ally Speight, Sophie Papa, Nick Powell	6
8	The Genetic Evolution of Metastasis 2022 ·Cancer Research ·Aljosja Rogiers, Irene Lobón, Lavinia Spain, Samra Turajlic	12
9	WHO 2022 landscape of papillary and chromophobe renal cell carcinoma 2022 ·Histopathology ·João Lobo, Riuko Ohashi, Mahul B. Amin, Daniel M. Berney, Éva Compérat, Ian A. Cree, Anthony J. Gill, Arndt Hartmann, Santosh Menon, George J. Netto, Maria Rosaria Raspollini, Mark A. Rubin, Puay Hoon Tan, Satish K. Tickoo, Toyonori Tsuzuki, Samra Turajlic, Ming Zhou, John R. Srigley, Holger Moch	61
10	The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs—Part B: Prostate and Urinary Tract Tumors breakdown → 2022 ·European Urology ·George J. Netto, Mahul B. Amin, Daniel M. Berney, Éva Compérat, Anthony J. Gill, Arndt Hartmann, Santosh Menon, Maria Rosaria Raspollini, Mark A. Rubin, John R. Srigley, Puay Hoon Tan, Satish K. Tickoo, Toyonori Tsuzuki, Samra Turajlic, Ian A. Cree, Holger Moch	140
11	A protocol for representative sampling of solid tumors to improve the accuracy of sequencing results 2021 ·STAR Protocols ·Lisa L. Gallegos, (unknown), Lavinia Spain, Stacey Stanislaw, Samantha M. Hill, (unknown), Carol Jones, (unknown), Zayd Tippu, Aoune Barhoumi, (unknown), Nelson R. Alexander, Samra Turajlic	6
12	Identification of conserved evolutionary trajectories in tumors 2020 ·Bioinformatics ·Ermin Hodzic, Raunak Shrestha, Salem Malikić, Colin C. Collins, Kevin Litchfield, Samra Turajlic, S. Cenk Şahinalp	9
13	Summary from the Kidney Cancer Association’s Inaugural Think Thank: Coalition for a Cure 2020 ·Clinical Genitourinary Cancer ·Brian I. Rini, E. Jason Abel, Laurence Albigès, Axel Bex, James Brugarolas, Ronald M. Bukowski, Jonathan Coleman, Charles G. Drake, Robert A. Figlin, Andy Futreal, Hans J. Hammers, Thomas Powles, W. Kimryn Rathmell, Christopher J. Ricketts, Samra Turajlic, Christopher G. Wood, Bradley C. Leibovich	3
14	Escape from nonsense-mediated decay associates with anti-tumor immunogenicity 2020 ·Nature Communications ·Kevin Litchfield, James L. Reading, Emilia L. Lim, Hang Xu, Po Liu, Maise Al-Bakir, Yien Ning Sophia Wong, Andrew Rowan, Samuel A. Funt, Taha Merghoub, David Perkins, Martin Lauss, Inge Marie Svane, Göran Jönsson, Javier Herrero, James Larkin, Sergio A. Quezada, Matthew D. Hellmann, Samra Turajlic, Charles Swanton	68
15	CAPTURE: Cancer and COVID-19 antiviral immune monitoring study 2020 ·Clinical Cancer Research ·Annika Fendler, (unknown), Lewis Au, Scott T.C. Shepherd, Fiona Byrne, Kim Edmonds, (unknown), Lyra Del Rosario, Benjamin Shum, James Larkin, Lisa Pickering, Andrew J.S. Furness, Samra Turajlic, (unknown)	0
16	Tumour mutational burden: primary versus metastatic tissue creates systematic bias 2019 ·Immuno-Oncology Technology ·Désirée Schnidrig, Samra Turajlic, Kevin Litchfield	27
17	An immunotherapy survivor population: health-related quality of life and toxicity in patients with metastatic melanoma treated with immune checkpoint inhibitors 2019 ·Supportive Care in Cancer ·Aine O’Reilly, (unknown), (unknown), (unknown), Jhia Jiat Teh, Emma McLean, Kim Edmonds, Karla Lingard, (unknown), Joanna Lynch, Lewis Au, (unknown), Natalie Pattison, Theresa Wiseman, Samra Turajlic, Martin Gore, James Larkin, Olga Husson	52
18	Real-World EQ-5D-5L Utility Values In Patients With Melanoma Derived Using A Digital ‘Bring Your Own Device’ Platform 2018 ·Value in Health ·James Larkin, (unknown), Donald M. Cannon, Lewis Au, Lavinia Spain, Nikki Hunter, Samra Turajlic, Andrew Nixon, (unknown), (unknown), Theresa Wiseman	0
19	The mutational burden of acral melanoma revealed by whole‐genome sequencing and comparative analysis 2014 ·Pigment Cell & Melanoma Research ·Simon J. Furney, Samra Turajlic, Gordon Stamp, Janet Thomas, Andrew Hayes, D. Strauß, Mike Gavrielides, Xing Wei, Martin Gore, James Larkin, Richard Marais	80
20	Inhibiting EGF Receptor or SRC Family Kinase Signaling Overcomes BRAF Inhibitor Resistance in Melanoma 2012 ·Cancer Discovery ·María Romina Girotti, Malin Pedersen, Berta Sanchez‐Laorden, Amaya Virós, Samra Turajlic, Dan Niculescu‐Duvaz, Alfonso Zambon, John Sinclair, Andrew Hayes, Martin Gore, Paul Lorigan, Caroline J. Springer, James Larkin, Claus Jørgensen, Richard Marais	272

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact